• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液嗜酸性粒细胞计数与 COPD 患者肺炎住院风险的关系。

Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD.

机构信息

Dept of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.

The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Eur Respir J. 2018 May 24;51(5). doi: 10.1183/13993003.00120-2018. Print 2018 May.

DOI:10.1183/13993003.00120-2018
PMID:29650563
Abstract

Blood eosinophil count in chronic obstructive pulmonary disease (COPD) is associated with higher exacerbation rate and favourable response to corticosteroids; however, frequent exacerbations and use of inhaled corticosteroids could elevate pneumonia risk. We tested the hypothesis that high blood eosinophil counts are associated with high risk of pneumonia in individuals with severe COPD from the general population.We included 7180 individuals with COPD from the Copenhagen General Population Study, including 643 with forced expiratory volume in 1 s (FEV) <50% predicted between 2003 and 2011. All primary discharge diagnoses of pneumonia during follow-up were recorded.Among individuals with COPD and FEV <50% pred, the multivariable adjusted incidence rate ratio was 2.17 (95% CI 1.31-3.58) for pneumonia comparing individuals with blood eosinophil counts ≥0.34×10 cells·L <0.34×10 cells·L In individuals with clinical COPD, defined by recent exacerbation, ≥10 pack-years of smoking and FEV <70% pred, the corresponding risk was 4.52 (2.11-9.72). Risk of pneumonia did not differ by blood eosinophil count in individuals with COPD and FEV ≥50% pred.In individuals with COPD and FEV <50% pred, blood eosinophil count ≥0.34×10 cells·L was associated with high risk of hospitalisation due to pneumonia.

摘要

血液嗜酸性粒细胞计数与慢性阻塞性肺疾病(COPD)的更高恶化率和对皮质类固醇的有利反应相关;然而,频繁恶化和使用吸入皮质类固醇可能会增加肺炎的风险。我们检验了这样一个假设,即高血液嗜酸性粒细胞计数与一般人群中重度 COPD 患者的高肺炎风险相关。

我们纳入了来自哥本哈根普通人群研究的 7180 名 COPD 患者,其中包括 2003 年至 2011 年期间有 643 名用力呼气量(FEV)<50%预测值的患者。在随访期间,所有肺炎的主要出院诊断均被记录下来。

在 FEV <50% pred 的 COPD 患者中,与血液嗜酸性粒细胞计数≥0.34×10⁹细胞·L⁻¹相比,血液嗜酸性粒细胞计数≥0.34×10⁹细胞·L⁻¹的患者肺炎的多变量校正发病率比为 2.17(95%CI 1.31-3.58)。在由近期恶化、≥10 包年吸烟史和 FEV <70% pred 定义的有临床 COPD 的患者中,相应的风险为 4.52(2.11-9.72)。在 FEV ≥50% pred 的 COPD 患者中,肺炎的风险并未因血液嗜酸性粒细胞计数而有所不同。

在 FEV <50% pred 的 COPD 患者中,血液嗜酸性粒细胞计数≥0.34×10⁹细胞·L⁻¹与因肺炎住院的高风险相关。

相似文献

1
Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD.血液嗜酸性粒细胞计数与 COPD 患者肺炎住院风险的关系。
Eur Respir J. 2018 May 24;51(5). doi: 10.1183/13993003.00120-2018. Print 2018 May.
2
Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.血嗜酸性粒细胞计数与慢性阻塞性肺疾病患者肺炎风险:一项基于患者的荟萃分析。
Lancet Respir Med. 2016 Sep;4(9):731-741. doi: 10.1016/S2213-2600(16)30148-5. Epub 2016 Jul 23.
3
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的炎症生物标志物与加重。
JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.
4
Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.血液嗜酸性粒细胞与慢性阻塞性肺疾病恶化。哥本哈根普通人群研究。
Am J Respir Crit Care Med. 2016 May 1;193(9):965-74. doi: 10.1164/rccm.201509-1869OC.
5
Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.非哮喘-慢性阻塞性肺疾病(COPD)重叠综合征患者血液嗜酸性粒细胞计数的临床意义。
Int J Chron Obstruct Pulmon Dis. 2017 Aug 17;12:2455-2464. doi: 10.2147/COPD.S129321. eCollection 2017.
6
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.痰和血嗜酸性粒细胞浓度与 COPD 严重程度的临床指标的关联:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13.
7
Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.英国临床实践研究数据链中不同血液嗜酸性粒细胞水平的慢性阻塞性肺疾病患者的人口统计学和临床特征
COPD. 2018 Apr;15(2):177-184. doi: 10.1080/15412555.2018.1441275. Epub 2018 Mar 20.
8
Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.血嗜酸性粒细胞作为 COPD 患者吸入皮质类固醇激素反应的标志物。
Eur Respir J. 2016 May;47(5):1374-82. doi: 10.1183/13993003.01370-2015. Epub 2016 Feb 25.
9
Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.丹麦一般人群中无症状和有症状、未经诊断的 COPD 的预后:一项前瞻性队列研究。
Lancet Respir Med. 2017 May;5(5):426-434. doi: 10.1016/S2213-2600(17)30119-4. Epub 2017 Apr 4.
10
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.血液嗜酸性粒细胞计数、加重情况以及慢性阻塞性肺疾病患者添加吸入氟替卡松维兰特罗后的反应:两项平行随机对照试验数据的二次分析。
Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12.

引用本文的文献

1
Eosinophilia Is a Favorable Marker for Pneumonia in Chronic Obstructive Pulmonary Disease.嗜酸性粒细胞增多是慢性阻塞性肺疾病患者肺炎的有利标志物。
Tuberc Respir Dis (Seoul). 2024 Oct;87(4):465-472. doi: 10.4046/trd.2023.0174. Epub 2024 May 3.
2
Association of blood eosinophils with corticosteroid treatment failure stratified by smoking status among inpatients with AECOPD.吸烟状况分层的 AECOPD 住院患者中血嗜酸性粒细胞与皮质类固醇治疗失败的相关性。
BMJ Open Respir Res. 2024 Apr 12;11(1):e001634. doi: 10.1136/bmjresp-2023-001634.
3
Risk of adverse reactions associated with inhaled corticosteroids for chronic obstructive pulmonary disease: A meta-analysis.
与慢性阻塞性肺疾病相关的吸入性皮质类固醇不良反应风险:一项荟萃分析。
Medicine (Baltimore). 2024 Jan 19;103(3):e36609. doi: 10.1097/MD.0000000000036609.
4
Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD.比较 COPD 患者使用长效抗胆碱能药物和吸入性皮质类固醇加长效β激动剂的肺炎发生率。
Sci Rep. 2023 May 20;13(1):8183. doi: 10.1038/s41598-023-35223-3.
5
Decreased capsaicin cough reflex sensitivity predicts hospitalisation due to COPD.辣椒素咳嗽反射敏感性降低可预测 COPD 住院。
BMJ Open Respir Res. 2023 Jan;10(1). doi: 10.1136/bmjresp-2022-001283.
6
Using inflammatory index to distinguish asthma, asthma-COPD overlap and COPD: A retrospective observational study.利用炎症指标区分哮喘、哮喘-慢性阻塞性肺疾病重叠综合征和慢性阻塞性肺疾病:一项回顾性观察研究。
Front Med (Lausanne). 2022 Nov 17;9:1045503. doi: 10.3389/fmed.2022.1045503. eCollection 2022.
7
Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts' review.单吸入器三联疗法在阻塞性气道疾病管理中的应用:印度医学专家综述
ERJ Open Res. 2022 Mar 28;8(1). doi: 10.1183/23120541.00556-2021. eCollection 2022 Jan.
8
The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.52周单吸入器装置三联疗法与双联疗法对慢性阻塞性肺疾病患者死亡率的影响:一项随机对照试验的系统评价和荟萃分析
Life (Basel). 2022 Jan 25;12(2):173. doi: 10.3390/life12020173.
9
Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.慢性阻塞性肺疾病嗜酸性表型:与哮喘的异同。
Korean J Intern Med. 2021 Nov;36(6):1305-1319. doi: 10.3904/kjim.2021.180. Epub 2021 Oct 12.
10
Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.血液嗜酸性粒细胞计数指导的皮质类固醇治疗作为慢性阻塞性肺疾病急性加重的预后生物标志物:一项系统评价和荟萃分析。
Ther Adv Chronic Dis. 2021 Jul 7;12:20406223211028768. doi: 10.1177/20406223211028768. eCollection 2021.